Newsroom

- Top-line readout of clinical study results anticipated by the end of 2021 SEATTLE, Sept. 7, 2021 /PRNewswire/ -- OnQuality...

Link to Episode: http://thebioreport.com/2021/07/22/targeting-cancer-drug-side-effects-at-their-source/ While great strides have been...

Episode link: https://www.reorientpodcast.com/episodes/hong-tang Dr. Hong Tang is the Chief Medical Officer and co-founder of OnQuality...

Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer...

By Wayne Koberstein This article draws on the experience of five company CEOs with various backgrounds and views of stealth transitions....

Dr. Michael McCullar, CEO, and Dr. Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company...

SEATTLE, June 9, 2021 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted cancer supportive care company developing...

By Kezia Parkins OnQuality’s chief medical officer and co-founder Hong Tang discusses the firm’s pipeline of cancer supportive care...

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings SEATTLE, May 19,...

On the new Prognosis Ohio, part of the WCBE Podcast Experience, Dan Skinner talks with OSU dermatologist and researcher, Benjamin...